Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan.

OBJECTIVE The objective of the study is to describe recent epidemiologic patterns of Kawasaki disease based on information included in patient records that had been obtained through a nationwide hospital survey in Japan. METHODS A questionnaire and diagnostic criteria for Kawasaki disease that had been approved by the Kawasaki Disease Research Committee were sent to all pediatric departments of hospitals (2638 hospitals) with a bed capacity of at least 100. The subjects all were new patients who were treated during a 2-year period from 1995 to 1996. RESULTS A total of 12 531 children contracted the disease during the observation period. The incidence was 102.6 for 1995 and 108.0 for 1996 per 100 000 children younger than age 5 years. The male:female ratio was 1.37. The age distribution pattern showed a peak near 6 months of age. Geographic variations in the incidence suggested the existence of local outbreaks. Cardiac sequelae were seen in 12% of the patients. CONCLUSION More than 6000 patients suffered from Kawasaki disease each year, and its annual incidence is increasing steadily. The probable existence of local outbreaks is worthy of note. Other epidemiologic patterns were unchanged from previous years.

[1]  H. Yanagawa,et al.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.

[2]  H. Yanagawa,et al.  NATIONWIDE EPIDEMIC OF KAWASAKI DISEASE IN JAPAN DURING WINTER OF 1985-86 , 1986, The Lancet.

[3]  T. Kawasaki,et al.  Temporal and geographical clustering of Kawasaki disease in Japan. , 1987, Progress in clinical and biological research.

[4]  H. Yanagawa,et al.  Nationwide survey on Kawasaki disease in Japan. , 1987, Pediatrics.

[5]  H. Yanagawa,et al.  A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. , 1988 .

[6]  H. Yanagawa,et al.  Kawasaki disease in families. , 1989, Pediatrics.

[7]  H. Yanagawa,et al.  Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. , 1991, Pediatrics.

[8]  H. Yanagawa,et al.  Mortality among children with Kawasaki disease in Japan. , 1992, The New England journal of medicine.

[9]  H. Yanagawa,et al.  Incidence rate of recurrent Kawasaki disease in Japan , 1994, Acta paediatrica.

[10]  H. Yanagawa,et al.  Nationwide surveillance of Kawasaki disease in Japan, 1984 to 1993. , 1995, The Pediatric infectious disease journal.

[11]  H. Yanagawa,et al.  Cardiac sequelae of Kawasaki disease in Japan over 10 years , 1995, Acta paediatrica Japonica : Overseas edition.

[12]  H. Yanagawa,et al.  Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. , 1995, Archives of pediatrics & adolescent medicine.

[13]  H. Yanagawa,et al.  Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey , 1995, Acta paediatrica.

[14]  H. Yanagawa,et al.  Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. , 1995, Pediatrics.

[15]  H. Yanagawa,et al.  Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey. , 1996, Journal of epidemiology.

[16]  H. Yanagawa,et al.  Mortality rates for patients with a history of Kawasaki disease in Japan. Kawasaki Disease Follow-up Group. , 1996, The Journal of pediatrics.

[17]  H. Yanagawa,et al.  Serum C‐reactive protein levels in patients with Kawasaki disease: from the results of nation‐wide surveys of Kawasaki disease in Japan , 1997, Acta paediatrica.

[18]  H. Yanagawa,et al.  Use of Intravenous γ-Globulin for Kawasaki Disease: Effects on Cardiac Sequelae , 1997, Pediatric Cardiology.

[19]  M. Norman,et al.  Dynamic properties of the aorta and of the foot microcirculation in adolescents with diabetes mellitus , 1997, Acta paediatrica.

[20]  H. Yanagawa,et al.  Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan , 1997, Acta paediatrica.

[21]  H. Yanagawa,et al.  Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae. , 1997, Pediatric cardiology.